Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07531043) titled 'An Evaluation of the Efficacy and Safety of FID 123472 Ophthalmic Solution for the Reduction of Ocular Redness' on April 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Alcon Research
Condition:
Ocular Hyperemia
Intervention:
Drug: Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 2026
Target Sample Size: 240
Countries of Recruitment:
United States
T...